MajesTEC-4: Phase 3 trial of Teclistamab plus Lenalidomide versus Lenalidomide in patients with newly diagnosed multiple myeloma


Cook G., Zamagni E., Boccadoro M., Spencer A., Delforge M., Reece D., ...More

63rd Annual Scientific Meeting of the British-Society-for-Haematology, Birmingham, England, 23 - 25 April 2023, vol.201, pp.57, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 201
  • City: Birmingham
  • Country: England
  • Page Numbers: pp.57
  • Ankara University Affiliated: Yes